The value of LAMP-2-ANCA seropositivity as a biomarker may be greatest among AAV patients who have MPO/PR3-ANCA-negative SVV, but more so in individuals with middle vessel vasculitis (MVV), namely, polyarteritis nodosa (PAN) and large vessel vasculitis (LVV), namely Takayasu’s arteritis (TAK). The gene discussed is LAMP2; the disease is polyarteritis nodosa.